Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $65.53 for the day, up 8.73% from the previous closing price of $60.27. In other words, the price has increased by $8.73 from its previous closing price. On the day, 55.08 million shares were traded. HIMS stock price reached its highest trading level at $66.43 during the session, while it also had its lowest trading level at $60.59.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 62.34. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 04, 2025, Needham reiterated its Buy rating and also lowered its target price recommendation from $61 to $65.
TD Cowen Downgraded its Buy to Hold on April 29, 2025, while the target price for the stock was maintained at $30.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 28 ’25 when Boughton Soleil sold 2,572 shares for $58.70 per share. The transaction valued at 150,976 led to the insider holds 155,593 shares of the business.
Boughton Soleil bought 2,572 shares of HIMS for $150,976 on Jul 28 ’25. On Jul 23 ’25, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 13,750 shares for $56.00 each. As a result, the insider received 770,000 and left with 278,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 14667710464 and an Enterprise Value of 14408392704. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 95.39, and their Forward P/E ratio for the next fiscal year is 68.83. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.22 while its Price-to-Book (P/B) ratio in mrq is 26.67. Its current Enterprise Value per Revenue stands at 8.075 whereas that against EBITDA is 104.653.
Stock Price History:
The Beta on a monthly basis for HIMS is 2.08, which has changed by 2.5402486 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is 22.34%, while the 200-Day Moving Average is calculated to be 72.75%.
Shares Statistics:
HIMS traded an average of 46.21M shares per day over the past three months and 36182060 shares per day over the past ten days. A total of 215.21M shares are outstanding, with a floating share count of 190.44M. Insiders hold about 14.92% of the company’s shares, while institutions hold 69.98% stake in the company. Shares short for HIMS as of 1752537600 were 65295727 with a Short Ratio of 1.41, compared to 1749772800 on 61690896. Therefore, it implies a Short% of Shares Outstanding of 65295727 and a Short% of Float of 36.230000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
